Funded Tech Companies

TRexBio

Headquartered in San Francisco, TRexBio has funding from Eli Lilly and Company, Pfizer Venture Investments and Alexandria Venture Investments.

Company Overview

Contact Information

Company Background Information

Overview

TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/14/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Johnston Erwin

        

Chief Medical Officer

Ovid Trifan

        

Chief Scientific Officer

Melanie Kleinschek

        

VP - Bus. Development

Laura Berner

        

Company Investors

• Eli Lilly and Company
• Pfizer Venture Investments
• Alexandria Venture Investments (Joel Marcus)
• Johnson & Johnson Development Corporation
• Delos Capital (Eric Huang)
• Avego Healthcare Capital (Eric Pham)
• Polaris Partners
• Agent Capital
• SV Health Investors

Browse more funded tech companies:

Trevi Therapeutics | Trexel

Share this article

About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary